Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 841468, 5 pages
http://dx.doi.org/10.1155/2009/841468
Research Article

Relationship between Estradiol and Antioxidant Enzymes Activity of Ischemic Stroke

1Department of Biochemistry & Nutrition, School of Medicine, Hamadan University of Medical Sciences, 65178/518 Hamadan, Iran
2Department of Neurology, Hamadan University of Medical Sciences, 65178/518 Hamadan, Iran
3Department of Clinical Biochemistry, Faculty of Medicine, Kermanshah University of Medical Science, 6714869914 Kermanshah, Iran
4Department of Biochemistry, Faculty of Medicine, Zahedan University of Medical Science, 4318198167 Zahedan, Iran

Received 26 March 2009; Revised 5 July 2009; Accepted 24 July 2009

Academic Editor: Xudong Huang

Copyright © 2009 Nasrin Sheikh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. de Leciñana, J. A. Egido, C. Fernández et al., “Risk of ischemic stroke and lifetime estrogen exposure,” Neurology, vol. 68, no. 1, pp. 33–38, 2007. View at Publisher · View at Google Scholar
  2. M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee, “Endogenous sex hormones and cardiovascular disease in men,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5076–5086, 2003. View at Publisher · View at Google Scholar
  3. P. Jousilahti, E. Vartiainen, J. Tuomilehto, and P. Puska, “Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland,” Circulation, vol. 99, no. 9, pp. 1165–1172, 1999. View at Google Scholar
  4. D. W. Brann, K. Dhandapani, C. Wakade, V. B. Mahesh, and M. M. Khan, “Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications,” Steroids, vol. 72, no. 5, pp. 381–405, 2007. View at Publisher · View at Google Scholar
  5. A. A. Miller, T. M. De Silva, K. A. Jackman, and C. G. Sobey, “Effect of gender and sex hormones on vascular oxidative stress,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 10, pp. 1037–1043, 2007. View at Publisher · View at Google Scholar
  6. R. D. Abbott, L. J. Launer, B. L. Rodriguez et al., “Serum estradiol and risk of stroke in elderly men,” Neurology, vol. 68, no. 8, pp. 563–568, 2007. View at Publisher · View at Google Scholar
  7. K. Prokai-Tatrai, P. Perjesi, N. M. Rivera-Portalatin, J. W. Simpkins, and L. Prokai, “Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative,” Steroids, vol. 73, no. 3, pp. 280–288, 2008. View at Publisher · View at Google Scholar
  8. M. Alonso de Lecinana and J. A. Egido, “Estrogens as neuroprotectants against ischemic stroke,” Cerebrovascular Diseases, vol. 21, supplement 2, pp. 48–53, 2006. View at Publisher · View at Google Scholar
  9. C. Zimmermann, K. Winnefeld, S. Streck, M. Roskos, and R. L. Haberl, “Antioxidant status in acute stroke patients and patients at stroke risk,” European Neurology, vol. 51, no. 3, pp. 157–161, 2004. View at Publisher · View at Google Scholar
  10. A. Cherubini, M. C. Polidori, M. Bregnocchi et al., “Antioxidant profile and early outcome in stroke patients,” Stroke, vol. 31, pp. 2295–2300, 2000. View at Google Scholar
  11. G. Ferretti, T. Bacchetti, S. Masciangelo et al., “Lipid peroxidation in stroke patients,” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 1, pp. 113–117, 2008. View at Publisher · View at Google Scholar
  12. T. Carbonell and R. Rama, “Iron, oxidative stress and early neurological deterioration in ischemic stroke,” Current Medicinal Chemistry, vol. 14, no. 8, pp. 857–874, 2007. View at Publisher · View at Google Scholar
  13. D. L. van der A, D. E. Grobbee, M. Roest, J. J. M. Marx, H. A. Voorbij, and Y. T. van der Schouw, “Serum ferritin is a risk factor for stroke in postmenopausal women,” Stroke, vol. 36, no. 8, pp. 1637–1641, 2005. View at Publisher · View at Google Scholar
  14. R. Cote, R. N. Battista, C. Wolfson, J. Boucher, J. Adam, and V. Hachinski, “The Canadian Neurological Scale: validation and reliability assessment,” Neurology, vol. 39, no. 5, pp. 638–643, 1989. View at Google Scholar
  15. I. Margaill, M. Plotkine, and D. Lerouet, “Antioxidant strategies in the treatment of stroke,” Free Radical Biology and Medicine, vol. 39, no. 4, pp. 429–443, 2005. View at Publisher · View at Google Scholar
  16. P. A. Kocaturk, M. C. Akbostanci, C. Isikay et al., “Antioxidant status in cerebrovascular accident,” Biological Trace Element Research, vol. 80, no. 2, pp. 115–124, 2001. View at Publisher · View at Google Scholar
  17. P. Bertrand, M. Starck, B. Herbeth, M. Vincent-Viry, F. Schiele, and G. Siest, “Serum total antioxidant status is higher in postmenopausal women and after estrogen replacement therapy,” Clinical Chemistry and Laboratory Medicine, vol. 40, no. 8, pp. 850–852, 2002. View at Publisher · View at Google Scholar
  18. B. Moosmann and C. Behl, “The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 8867–8872, 1999. View at Publisher · View at Google Scholar
  19. D. Amantea, R. Russo, G. Bagetta, and M. T. Corasaniti, “From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens,” Pharmacological Research, vol. 52, no. 2, pp. 119–132, 2005. View at Publisher · View at Google Scholar